New Class of Drug Modalities: Directed Evolution of a De Novo Designed Helix–Loop–Helix Peptide to Bind VEGF for Tumor Growth Inhibition

Details 詳細情報について

• CRID

  1050301076279009536

• DOI

  10.1021/acschembio.1c00940

• ISSN

  15548937

  15548929

• HANDLE

  10466/0002001066

• PubMed

  35176860

• Web Site

  https://omu.repo.nii.ac.jp/records/2001066

  https://pubs.acs.org/doi/pdf/10.1021/acschembio.1c00940

• Text Lang

  en

• Article Type

  journal article

• Data Source

  • IRDB
  • Crossref
  • KAKEN
  • OpenAIRE